本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.85
-0.1600-7.96%
盘后:1.870.0198+1.07%19:55 EDT
成交量:90.17万
成交额:171.06万
市值:2.21亿
市盈率:-1.32
高:2.00
开:1.99
低:1.85
收:2.01
52周最高:5.55
52周最低:1.03
股本:1.20亿
流通股本:1.09亿
量比:0.92
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-1.4029
每股收益(LYR):-1.2813
净资产收益率:-179.10%
总资产收益率:-62.95%
市净率:19.34
市盈率(LYR):-1.44

数据加载中...

2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

SEC问询函

Form CORRESP - Correspondence
2023/08/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans